IP Library Granted Patent US 10,688,069
Granted Patent B2
US 10,688,069 · App. 15/474,375 · Granted Jun 23, 2020

Sports health performance composition

Inventors: Beth Anne-Szkudlarek Brown (Jackson, WY); Anthony Lemus (Jackson, WY); Marnie L. Peterson (Jackson, WY)
Assignee: REV Pharmaceuticals LLC
A61K31/198A61K9/0014A61K9/107A61K31/352A61K45/06A61K47/183A61N1/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,688,069
App. No.
15/474,375
Granted
Jun 23, 2020
Kind
B2
Abstract

A topical composition that includes L-arginine that is used as a sports health composition. The composition can further include forskolin. Disclosed is a method of using the topical composition.

Claims (7)

1. A topical composition comprising about 20-40 wt % L-arginine, about 0.01-1 wt % forskolin, about 10-35 wt % skin penetration enhancer consisting of a mixture of methyl salicylate and menthol, and about 40-70 wt % base or carrier component, the composition dilating blood vessels to thereby allow lactic acid to dissipate from muscular tissue during exercise or during the recovery phase after exercise.

2. The topical composition of claim 1 , wherein the L-arginine is L-arginine ethyl ester, L-arginine hydrochloride or a free base of L-arginine.

3. The topical composition of claim 1 , wherein the base is selected from oil in water emulsion or water in oil emulsion, anhydrous silicone base, lipophilic foam base, transdermal cream base, or transdermal gel base.

4. The topical composition of claim 1 , wherein methyl salicylate is in a range of about 10 wt % to 20 wt % based on the total weight of the topical composition.

5. The topical composition of claim 1 , wherein the topical composition is in the form of a gel, cream, ointment, foam, spray or patch.

6. The topical composition of claim 1 , wherein the topical composition further comprises a pain reliever and/or a muscle relaxant.

7. The topical composition of claim 1 , wherein the 10-35 wt % skin penetration enhancer consisting of a mixture of methyl salicylate and menthol consists of about 1-16 wt % menthol with the remainder consisting of methyl salicylate.

Assignments (3)
CHANGE OF NAME Recorded Jan 18, 2022
From: ORENDA BIOSCIENCES, LLC
To: REV PHARMACEUTICALS, INC.
Reel/Frame 058767/0404 →
CHANGE OF NAME Recorded Jan 11, 2022
From: REV PHARMACEUTICALS, LLC
To: ORENDA BIOSCIENCES, LLC
Reel/Frame 058700/0528 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2017
From: BROWN, BETH ANNE-SZKUDLAREK; LEMUS, ANTHONY; PETERSON, MARNIE L.
To: REV PHARMACEUTICALS LLC
Reel/Frame 041799/0564 →
Continuity (2)
Provisional Application 62315859 · Mar 31, 2016
Related Publication 20170281581A1 · Oct 5, 2017